Pulmonary Fibrosis: What Causes IPF?
Learn more about Idiopathic Pulmonary Fibrosis: https://bit.ly/1QiRmr3…
Pulmonary Fibrosis: What Causes IPF?
Pulmonary Fibrosis Clinical Trials
Clinical trials are well-designed studies that collect information about new treatments for diseases and disorders. Most of the time, this means medications but clinical trials can also test other things such as stem cell therapies, surgical techniques, tests for diagnosis, medical devices and others. In particular, clinical trials focus on…
Pulmonary Fibrosis Foundation Sets Scientific Record at Upcoming Summit
The Pulmonary Fibrosis Foundation (PFF) recently announced that the number of scientific poster presentations on idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases (ILD) to be displayed at the upcoming PFF Summit 2015: From Bench to Bedside in Washington, D.C., reached a record. The PFF Summit 2015: From…
Pulmonary Fibrosis Awareness
Help raise awareness for this serious and devastating disease. Learn more about Pulmonary Fibrosis: https://bit.ly/1lfMsiZ…
How Are Idiopathic Pulmonary Fibrosis Treatments Advancing?
Sixty-six year old Dan Castner was living life to the fullest when he started experiencing difficulties in breathing. While he worked in the outdoor industry for more than 40 years and was used to biking, climbing, camping, skiing and hiking, in March of 2012 his life completely changed. Castner was…
Last Week’s Top-3 Most Read Posts On Pulmonary Fibrosis
1. Lung Stem Cell Spheroids Could Offer Cheap, Rapid Pulmonary Fibrosis Therapy 2. Genentech to Help Lead Pulmonary Fibrosis Foundation Programs 3. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015…
PF Foundation and Boehringer Partner to Advance Research, Aid Patients
The Pulmonary Fibrosis Foundation (PFF) recently announced in a press release a five-year collaboration with Boehringer Ingelheim to support PFF programs dedicated to the improvement of the clinical outcome in patients with pulmonary fibrosis (PF), increase awareness about the disease, and offer advance care, disease education and…
Idiopathic Pulmonary Fibrosis: Fibroblasts More Agresssive With USP13 Loss
In a recent study entitled “Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis,” a team of researchers investigated the differences in gene expression in fibroblast foci in patients with idiopathic pulmonary fibrosis (IPF). They found that the expression of a particular gene, USP13, was…
Idiopathic Pulmonary Fibrosis: The Simple Facts
“Watch this video for some facts on Idiopathic Pulmonary Fibrosis.” Read more about IPF: https://bit.ly/1QiRmr3…
Genentech to Help Support Pulmonary Fibrosis Foundation Programs
The Pulmonary Fibrosis Foundation (PFF), an organization whose goal is to raise awareness, offer disease education, advance care, and fund research in the field of pulmonary fibrosis (PF), announced in a press release that Genentech, a biotechnology company part of the Roche Group, will assume the role of Founding…
